Nahuel Zamponi

6PUBLICATIONS
56CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMicrofluidics and nanofluidics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 06, 2023
XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer Cells.

Rossella Marullo, Sarah C Rutherford, Maria V Revuelta

|Aug 18, 2022
Endothelial cell-leukemia interactions remodel drug responses, uncovering T-ALL vulnerabilities.

Luca Vincenzo Cappelli, Danilo Fiore, Jude M Phillip

|Jul 06, 2022
Inhibition of Integrin αVβ3 Signaling Improves the Antineoplastic Effect of Bexarotene in Cutaneous T-Cell Lymphoma.

Florencia Cayrol, Maria V Revuelta, Mercedes Debernardi

|Jun 03, 2022
BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL.

Min Xia, Liron David, Matt Teater

|Sep 04, 2021
Oncogenic HSP90 Facilitates Metabolic Alterations in Aggressive B-cell Lymphomas.

M Nieves Calvo-Vidal, Nahuel Zamponi, Jan Krumsiek

|Jan 12, 2018
Mitochondrial network complexity emerges from fission/fusion dynamics.

Nahuel Zamponi, Emiliano Zamponi, Sergio A Cannas

Pageof 1